Bellon Steven F.
- SEC CIK
- 0001831749
Latest role at each company
- FHTX Foghorn Therapeutics Inc.Chief Scientific Officeras of Feb 2, 2026
Trades
Every Form 4 that lists Bellon Steven F. as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| FHTXFoghorn Therapeutics Inc. | Sep 11, 2024 | Sep 9, 2024 | Bellon Steven F.Chief Scientific Officer | SSaleCommon Stock | −20K | $9.50 | −$190K | 101.96K | −16.4% | SEC10b5-1 |